FindTrial
Sign In

Therapeutic effect of new diet combined with artificial liver on malnutrition in patients with liver failure

End-stage liver disease Diet App combined with artificial liver improves liver failure malnutrition through the "entero-liver axis".

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104985
Enrollment
Unknown
Registered
2025-06-26
Start date
2023-10-24
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage liver disease/liver failure

Interventions

Experimental group:End-Stage Liver Disease Recipe App Guide

Sponsors

The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age< 75 years old; 2. Confirmed diagnosis of liver failure (acute, acute); 3. Patients without serious heart disease and diabetes; 4. Those who can eat normally through the digestive tract.

Exclusion criteria

Exclusion criteria: 1. Patients with severe renal disease; 2. Those who have taken nutritional products in the past 3 months; 3. Those who cannot perform according to the ESLDR APP.

Design outcomes

Primary

MeasureTime frame
Cholinesterase;Total protein;Albumin;Total bile acid;Biceps circumference;Triceps skinfold;Leucine;Isoleucine;Valine;Tyrosine;Body mass index;Total bilirubin;Aspartate aminotransferase;Alanine aminotransferase;Arm muscle circumference;Advantage hand grip strength;—

Countries

China

Contacts

Public ContactWang Jing

The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology

wangjinghappy2004@126.com+86 15849292939

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026